Fig. 2
From: Wee1 inhibitor PD0166285 sensitized TP53 mutant lung squamous cell carcinoma to cisplatin via STAT1
PD0166285 blocks G2/M phase of the cell cycle in a dose-dependent manner. a, b Flow cytometry analysis showing PD0166285-induced blockade of G2/M phase in LUSCs. c, d Western blot analysis demonstrating PD0166285-mediated inhibition of the cell cycle-related proteins in LUSCs. *p < 0.05, **p < 0.01, ***p < 0.001